Mark Sirgo is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Aug 2019: ArunA Bio, Inc. (Athens, GA — biotechnology — 2019; $13.3M reported sold to 81 investors).
What this means One deal on file with the SEC, filed Aug 2019. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Al Medwar (1 shared filing), Barry Storey (1 shared filing), C. William Griffin (1 shared filing), Darren DeVore (1 shared filing), Harold W. Ingalls (1 shared filing) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 court cases matching the name listed in Key records below.
What this means 3 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Mark Sirgo and found 3 differences: Same name, different state: "Mark Sirgo" (NC) is a separate record; Same name, different state: "Mark Sirgo" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.